Global Information
회사소개 | 문의

세계의 새로운 약물전달 시스템 시장 분석과 예측(2018-2025년)

Global Novel Drug Delivery Systems Market - Analysis and Forecasts 2018-2025

리서치사 QYResearch
발행일 2018년 06월 상품 코드 648105
페이지 정보 영문 171 Pages
가격
US $ 2,900 ₩ 3,227,900 PDF by E-mail (Single User License)
US $ 5,800 ₩ 6,455,900 PDF by E-mail (Enterprise Wide License)


세계의 새로운 약물전달 시스템 시장 분석과 예측(2018-2025년) Global Novel Drug Delivery Systems Market - Analysis and Forecasts 2018-2025
발행일: 2018년 06월 페이지 정보 : 영문 171 Pages

한글목차

새로운 약물전달 시스템 시장은 과거 수년간 평균 2.17%의 성장률로 상승세로 전환하며, 2017년의 매출 규모는 약 265억 달러로 추산되고 있습니다.

세계의 새로운 약물전달 시스템 시장을 조사했으며, 시장 및 시스템의 개요, 매출·총이익의 추이와 예측, 종류·용도·지역 등 각종 부문별 내역, 시장 성장에 대한 각종 영향요인 분석, 경쟁 환경과 시장 점유율, 주요 제조업체의 개요 등을 정리하여 전해드립니다.

제1장 시장 개요

  • 제품 개요·조사 범위
  • 시장 부문 : 종류별
    • 매출
    • 매출 점유율
    • 리포솜
    • 페길화 단백질·폴리펩티드
    • 고분자 나노입자
    • 항체약물결합체
  • 시장 부문 : 용도별
    • 매출 비교
    • 병원·진료소
    • 암치료센터
  • 시장 추이·전망 : 지역별
  • 시장 규모 추이·예측

제2장 경쟁 환경·제조업체

  • 매출·점유율 : 제조업체별
  • 총이익 : 제조업체별
  • 제조업체의 본부·설립년 등
  • 경쟁 구도·동향

제3장 매출·총이익 추이 : 지역별

제4장 매출 추이 : 종류별

제5장 매출 추이 : 용도별

제6장 주요 제조업체의 개요·분석

  • Amgen
  • Teva
  • UCB(Union Chimique Belge)
  • Roche
  • Celgene
  • Sanofi
  • Merck
  • Johnson & Johnson
  • Takeda
  • Gilead Sciences
  • Pfizer
  • Dr Reddy
  • Samyang BioPharmaceuticals
  • TOLMAR
  • Astellas
  • AMAG Pharmaceuticals
  • AstraZeneca
  • AbbVie
  • Bausch&Lomb
  • TWi Pharmaceuticals
  • Novartis
  • Aspen
  • Shire
  • Breckenridge Pharmaceuticals
  • Galen

제7장 제조 비용 분석

  • R&D 비용 분석
  • 제조 비용 구조
  • 제조 프로세스 분석

제8장 산업 체인·조달 전략·Downstream 바이어

제9장 마케팅 전략 분석·유통판매업체

  • 마케팅 경로
  • 시장 포지셔닝
  • 유통판매업체 리스트

제10장 시장 영향요인 분석

  • 기술의 진보와 리스크
  • 소비자의 요구와 고객 선호도의 변화
  • 정치 경제 환경의 변화

제11장 시장 예측

  • 매출 예측
  • 매출 예측 : 지역별
  • 매출 예측 : 종류별
  • 매출 예측 : 용도별

제12장 조사 결과·결론

제13장 조사 방법·데이터 소스

KSA 18.06.14

영문목차

Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.

This report studies the Novel Drug Delivery Systems market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Novel Drug Delivery Systems market by product type and applications/end industries.

In the last several years, global market of Novel Drug Delivery Systems developed smoothly, with an average growth rate of 2.17%. In 2017, global revenue of Novel Drug Delivery Systems is nearly 26.5 billion USD.

The major players in global Novel Drug Delivery Systems market include:

  • Amgen
  • Teva
  • UCB (Union Chimique Belge)
  • Roche
  • Celgene
  • Sanofi
  • Merck
  • Johnson & Johnson
  • Takeda
  • Gilead Sciences
  • Pfizer
  • Dr Reddy
  • Samyang Biopharmaceuticals
  • TOLMAR
  • Astellas
  • AMAG Pharmaceuticals
  • AstraZeneca
  • AbbVie
  • Bausch&Lomb
  • TWi Pharmaceuticals
  • Novartis
  • Aspen
  • Shire
  • Breckenridge Pharmaceuticals
  • Galen

Geographically, this report is segmented into several key regions, with revenue, market share and growth rate of Novel Drug Delivery Systems in these regions, from 2013 to 2025 (forecast), covering:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa

On the basis of product, the Novel Drug Delivery Systems market is primarily split into:

  • Liposomes
  • PEGylated Proteins & Polypeptides
  • Polymer Nanoparticle
  • Protein-drug Conjugates
  • Others

On the basis on the end users/applications, this report covers:

  • Hospitals & Clinic
  • Cancer Treatment Centers
  • Others

Table of Contents

1 Novel Drug Delivery Systems Market Overview

  • 1.1 Product Overview and Scope of Novel Drug Delivery Systems
  • 1.2 Novel Drug Delivery Systems Segment by Types (Product Category)
    • 1.2.1 Global Novel Drug Delivery Systems Revenue by Types
    • 1.2.2 Global Novel Drug Delivery Systems Revenue Market Share by Types in 2017
    • 1.2.3 Liposomes
    • 1.2.4 PEGylated Proteins & Polypeptides
    • 1.2.5 Polymer Nanoparticle
    • 1.2.6 Protein-drug Conjugates
  • 1.3 Global Novel Drug Delivery Systems Segment by Applications
    • 1.3.1 Global Novel Drug Delivery Systems Revenue Comparison by Applications
    • 1.3.2 Hospitals & Clinic
    • 1.3.3 Cancer Treatment Centers
  • 1.4 Global Novel Drug Delivery Systems Market by Regions (2013-2025)
    • 1.4.1 Global Novel Drug Delivery Systems Revenue Comparison by Regions (2013-2025)
    • 1.4.2 North America Novel Drug Delivery Systems Status and Prospect (2013-2025)
    • 1.4.3 Europe Novel Drug Delivery Systems Status and Prospect (2013-2025)
    • 1.4.4 Asia-Pacific Novel Drug Delivery Systems Status and Prospect (2013-2025)
    • 1.4.5 South America Novel Drug Delivery Systems Status and Prospect (2013-2025)
    • 1.4.6 Middle East and Africa Novel Drug Delivery Systems Status and Prospect (2013-2025)
  • 1.5 Global Novel Drug Delivery Systems Market Size (2013-2025)

2 Global Novel Drug Delivery Systems Market Competition by Manufacturers

  • 2.1 Global Novel Drug Delivery Systems Revenue and Share by Manufacturers (2017-2018)
  • 2.2 Global Novel Drug Delivery Systems Gross Margin by Manufacturers (2017-2018)
  • 2.3 Manufacturers Novel Drug Delivery Systems Headquarters, Established Date and Product
  • 2.4 Novel Drug Delivery Systems Market Competitive Situation and Trends
    • 2.4.1 Novel Drug Delivery Systems Market Concentration Rate
    • 2.4.2 Novel Drug Delivery Systems Market Share of Top 3 and Top 5 Manufacturers
    • 2.4.3 Mergers & Acquisitions, Expansion

3 Global Novel Drug Delivery Systems Revenue by Regions (2013-2018)

  • 3.1 Global Novel Drug Delivery Systems Revenue and Market Share by Regions (2013-2018)
  • 3.2 Global Novel Drug Delivery Systems Revenue and Gross Margin (2013-2018)
  • 3.3 North America Novel Drug Delivery Systems Revenue (2013-2018)
    • 3.3.1 North America Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
    • 3.3.2 North America Novel Drug Delivery Systems Revenue and Gross Margin (2013-2018)
  • 3.4 Europe Novel Drug Delivery Systems Revenue (2013-2018)
    • 3.4.1 Europe Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
    • 3.4.2 Europe Novel Drug Delivery Systems Revenue and Gross Margin (2013-2018)
  • 3.5 Asia-Pacific Novel Drug Delivery Systems Revenue (2013-2018)
    • 3.5.1 Asia-Pacific Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
    • 3.5.2 Asia-Pacific Novel Drug Delivery Systems Revenue and Gross Margin (2013-2018)
  • 3.6 South America Novel Drug Delivery Systems Revenue (2013-2018)
    • 3.6.1 South America Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
    • 3.6.2 South America Novel Drug Delivery Systems Revenue and Gross Margin (2013-2018)
  • 3.7 Middle East & Africa Novel Drug Delivery Systems Revenue (2013-2018)
    • 3.7.1 Middle East & Africa Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
    • 3.7.2 Middle East & Africa Novel Drug Delivery Systems Revenue and Gross Margin (2013-2018)

4 Global Novel Drug Delivery Systems Revenue (Value) by Types

  • 4.1 Global Novel Drug Delivery Systems Revenue and Market Share by Types (2013-2018)
  • 4.2 Global Novel Drug Delivery Systems Revenue Growth Rate by Types (2013-2018)

5 Global Novel Drug Delivery Systems Market Analysis by Applications

  • 5.1 Global Novel Drug Delivery Systems Revenue and Market Share by Applications (2013-2018)
  • 5.2 Global Novel Drug Delivery Systems Revenue Growth Rate by Applications (2013-2018)

6 Analysis of Novel Drug Delivery Systems Industry Key Manufacturers

  • 6.1 Amgen
    • 6.1.1 Company Profile
    • 6.1.2 Product Information
    • 6.1.3 Revenue, Cost, Gross Profit and Gross Margin
  • 6.2 Teva
    • 6.2.1 Company Profile
    • 6.2.2 Product Information
    • 6.2.3 Revenue, Cost, Gross Profit and Gross Margin
  • 6.3 UCB (Union Chimique Belge)
    • 6.3.1 Company Profile
    • 6.3.2 Product Information
    • 6.3.3 Revenue, Cost, Gross Profit and Gross Margin
  • 6.4 Roche
    • 6.4.1 Company Profile
    • 6.4.2 Product Information
    • 6.4.3 Revenue, Cost, Gross Profit and Gross Margin
  • 6.5 Celgene
    • 6.5.1 Company Profile
    • 6.5.2 Product Information
    • 6.5.3 Revenue, Cost, Gross Profit and Gross Margin
  • 6.6 Sanofi
    • 6.6.1 Company Profile
    • 6.6.2 Product Information
    • 6.6.3 Revenue, Cost, Gross Profit and Gross Margin
  • 6.7 Merck
    • 6.7.1 Company Profile
    • 6.7.2 Product Information
    • 6.7.3 Revenue, Cost, Gross Profit and Gross Margin
  • 6.8 Johnson & Johnson
    • 6.8.1 Company Profile
    • 6.8.2 Product Information
    • 6.8.3 Revenue, Cost, Gross Profit and Gross Margin
  • 6.9 Takeda
    • 6.9.1 Company Profile
    • 6.9.2 Product Information
    • 6.9.3 Revenue, Cost, Gross Profit and Gross Margin
  • 6.10 Gilead Sciences
    • 6.10.1 Company Profile
    • 6.10.2 Product Information
    • 6.10.3 Revenue, Cost, Gross Profit and Gross Margin
  • 6.11 Pfizer
    • 6.11.1 Company Profile
    • 6.11.2 Product Information
    • 6.11.3 Revenue, Cost, Gross Profit and Gross Margin
  • 6.12 Dr Reddy
    • 6.12.1 Company Profile
    • 6.12.2 Product Information
    • 6.12.3 Revenue, Cost, Gross Profit and Gross Margin
  • 6.13 Samyang Biopharmaceuticals
    • 6.13.1 Company Profile
    • 6.13.2 Product Information
    • 6.13.3 Revenue, Cost, Gross Profit and Gross Margin
  • 6.14 TOLMAR
    • 6.14.1 Company Profile
    • 6.14.2 Product Information
    • 6.14.3 Revenue, Cost, Gross Profit and Gross Margin
  • 6.15 Astellas
    • 6.15.1 Company Profile
    • 6.15.2 Product Information
    • 6.15.3 Revenue, Cost, Gross Profit and Gross Margin
  • 6.16 AMAG Pharmaceuticals
    • 6.16.1 Company Profile
    • 6.16.2 Product Information
    • 6.16.3 Revenue, Cost, Gross Profit and Gross Margin
  • 6.17 AstraZeneca
    • 6.17.1 Company Profile
    • 6.17.2 Product Information
    • 6.17.3 Revenue, Cost, Gross Profit and Gross Margin
  • 6.18 AbbVie
    • 6.18.1 Company Profile
    • 6.18.2 Product Information
    • 6.18.3 Revenue, Cost, Gross Profit and Gross Margin
  • 6.19 Bausch&Lomb
    • 6.19.1 Company Profile
    • 6.19.2 Product Information
    • 6.19.3 Revenue, Cost, Gross Profit and Gross Margin
  • 6.20 TWi Pharmaceuticals
    • 6.20.1 Company Profile
    • 6.20.2 Product Information
    • 6.20.3 Revenue, Cost, Gross Profit and Gross Margin
  • 6.21 Novartis
    • 6.21.1 Company Profile
    • 6.21.2 Product Information
    • 6.21.3 Revenue, Cost, Gross Profit and Gross Margin
  • 6.22 Aspen
    • 6.22.1 Company Profile
    • 6.22.2 Product Information
    • 6.22.3 Revenue, Cost, Gross Profit and Gross Margin
  • 6.23 Shire
    • 6.23.1 Company Profile
    • 6.23.2 Product Information
    • 6.23.3 Revenue, Cost, Gross Profit and Gross Margin
  • 6.24 Breckenridge Pharmaceuticals
    • 6.24.1 Company Profile
    • 6.24.2 Product Information
    • 6.24.3 Revenue, Cost, Gross Profit and Gross Margin
  • 6.25 Galen
    • 6.25.1 Company Profile
    • 6.25.2 Product Information
    • 6.25.3 Revenue, Cost, Gross Profit and Gross Margin

7 Novel Drug Delivery Systems Manufacturing Cost Analysis

  • 7.1 Novel Drug Delivery Systems Drugs R&D Cost Analysis
    • 7.1.1 Clinical Phase Costs
    • 7.1.2 Capitalized Costs
  • 7.2 Proportion of Manufacturing Cost Structure
    • 7.2.1 Raw Materials
    • 7.2.2 Labor Cost
      • 7.2.2.1 USA Labor Cost Analysis
      • 7.2.2.2 Europe Labor Costs Analysis
      • 7.2.2.3 Asia Labor Costs Analysis
    • 7.2.3 Other Costs Analysis
      • 7.2.3.1 USA Cost of Electricity Analysis
      • 7.2.3.2 USA Water Cost Analysis
      • 7.2.3.3 Europe Cost of Electricity Analysis
      • 7.2.3.4 Europe Water Cost Analysis
      • 7.2.3.5 China Cost of Electricity Analysis
      • 7.2.3.6 China Water Cost Analysis
  • 7.3 Manufacturing Process Analysis of Novel Drug Delivery Systems

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

  • 8.1 Novel Drug Delivery Systems Industrial Chain Analysis
  • 8.2 Upstream Raw Materials Sourcing
  • 8.3 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

  • 9.1 Marketing Channel
    • 9.1.1 Direct Marketing
    • 9.1.2 Indirect Marketing
    • 9.1.3 Marketing Channel Development Trend
  • 9.2 Market Positioning
    • 9.2.1 Pricing Strategy
    • 9.2.2 Brand Strategy
      • 9.2.2.1 Introducing pharmaceutical branding strategies
      • 9.2.2.2 Building pharmaceutical brands
      • 9.2.2.3 Communicating pharmaceutical brands
      • 9.2.2.4 Alternative brand models
      • 9.2.2.5 The future of pharmaceutical branding
  • 9.3 Distributors/Traders List

10 Market Effect Factors Analysis

  • 10.1 Technology Progress/Risk
  • 10.2 Consumer Needs/Customer Preference Change
  • 10.3 Economic/Political Environmental Change

11 Global Novel Drug Delivery Systems Market Forecast (2019-2025)

  • 11.1 Global Novel Drug Delivery Systems Revenue Forecast (2019-2025)
  • 11.2 Global Novel Drug Delivery Systems Revenue Forecast by Regions (2019-2025)
    • 11.2.1 North America Novel Drug Delivery Systems Revenue Forecast (2019-2025)
    • 11.2.2 Europe Novel Drug Delivery Systems Revenue Forecast (2019-2025)
    • 11.2.3 Asia-Pacific Novel Drug Delivery Systems Revenue Forecast (2019-2025)
    • 11.2.4 South America Novel Drug Delivery Systems Revenue Forecast (2019-2025)
    • 11.2.5 Middle East and Africa Novel Drug Delivery Systems Revenue and Revenue Forecast (2019-2025)
  • 11.3 Global Novel Drug Delivery Systems Revenue Forecast by Types (2019-2025)
  • 11.4 Global Novel Drug Delivery Systems Revenue Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

  • 13.1 Methodology/Research Approach
    • 13.1.1 Research Programs/Design
    • 13.1.2 Market Size Estimation
    • 13.1.3 Market Breakdown and Data Triangulation
  • 13.2 Data Source
    • 13.2.1 Secondary Sources
    • 13.2.2 Primary Sources
  • 13.3 Disclaimer
  • 13.4 Author List

List of Tables and Figures

  • Figure Product Picture of Novel Drug Delivery Systems
  • Table Global Novel Drug Delivery Systems Comparison by Types
  • Table Global Novel Drug Delivery Systems Revenue (M USD) and Growth Rate Comparison by Types (2013-2025)
  • Figure Global Novel Drug Delivery Systems Revenue Market Share by Types in 2017
  • Figure Product Picture of Liposomes
  • Figure Product Picture of PEGylated Proteins & Polypeptides
  • Figure Product Picture of Polymer Nanoparticle
  • Figure Product Picture of Protein-drug Conjugates
  • Table Global Novel Drug Delivery Systems Revenue (M USD) and Growth Rate Comparison by Applications (2013-2025)
  • Figure Global Novel Drug Delivery Systems Revenue Market Share by Applications in 2017
  • Figure Hospitals & Clinic Examples
  • Figure Cancer Treatment Centers Examples
  • Table Global Novel Drug Delivery Systems Revenue (M USD) Comparison by Regions (2013-2025)
  • Figure North America Novel Drug Delivery Systems Revenue (M USD) and Growth Rate (2013-2025)
  • Figure Europe Novel Drug Delivery Systems Revenue (M USD) and Growth Rate (2013-2025)
  • Figure Asia-Pacific Novel Drug Delivery Systems Revenue (M USD) and Growth Rate (2013-2025)
  • Figure South America Novel Drug Delivery Systems Revenue (M USD) and Growth Rate (2013-2025)
  • Figure Middle East and Africa Novel Drug Delivery Systems Revenue (M USD) and Growth Rate (2013-2025)
  • Figure Global Novel Drug Delivery Systems Revenue (M USD) Status and Outlook (2013-2025)
  • Table Global Novel Drug Delivery Systems Revenue (M USD) by Manufacturers (2017-2018)
  • Table Global Novel Drug Delivery Systems Revenue Share by Manufacturers (2017-2018)
  • Figure 2017 Global Novel Drug Delivery Systems Revenue Share by Manufacturers
  • Figure 2018 Global Novel Drug Delivery Systems Revenue Share by Manufacturers
  • Table Global Market Novel Drug Delivery Systems Gross Margin of Key Manufacturers (2017-2018)
  • Figure Global Market Novel Drug Delivery Systems Gross Margin of Key Manufacturers in 2017
  • Table Manufacturers Novel Drug Delivery Systems Headquarters and Established Date
  • Table Manufacturers Novel Drug Delivery Systems Product list
  • Figure 2017 Novel Drug Delivery Systems Revenue Market Share by Manufacturers
  • Figure 2017 Novel Drug Delivery Systems Revenue Market Share of Top 3 Manufacturers
  • Figure 2017 Novel Drug Delivery Systems Revenue Market Share of Top 5 Manufacturers
  • Table Mergers & Acquisitions, Expansion
  • Table Global Novel Drug Delivery Systems Revenue (M USD) by Regions (2013-2018)
  • Table Global Novel Drug Delivery Systems Revenue Market Share by Regions (2013-2018)
  • Figure Global Novel Drug Delivery Systems Revenue Market Share by Regions (2013-2018)
  • Figure 2017 Global Novel Drug Delivery Systems Revenue Market Share by Regions
  • Figure Global Novel Drug Delivery Systems Revenue (M USD) and Growth Rate (2013-2018)
  • Table Global Novel Drug Delivery Systems Revenue (M USD) and Gross Margin (2013-2018)
  • Figure North America Novel Drug Delivery Systems Revenue (M USD) and Growth Rate (2013-2018)
  • Table North America Novel Drug Delivery Systems Revenue (M USD) and Gross Margin (2013-2018)
  • Figure Europe Novel Drug Delivery Systems Revenue (M USD) and Growth Rate (2013-2018)
  • Table Europe Novel Drug Delivery Systems Revenue (M USD) and Gross Margin (2013-2018)
  • Figure Asia-Pacific Novel Drug Delivery Systems Revenue (M USD) and Growth Rate (2013-2018)
  • Table Asia-Pacific Novel Drug Delivery Systems Revenue (M USD) and Gross Margin (2013-2018)
  • Figure South America Novel Drug Delivery Systems Revenue (M USD) and Growth Rate (2013-2018)
  • Table South America Novel Drug Delivery Systems Revenue (M USD) and Gross Margin (2013-2018)
  • Figure Middle East & Africa Novel Drug Delivery Systems Revenue (M USD) and Growth Rate (2013-2018)
  • Table Middle East & Africa Novel Drug Delivery Systems Revenue (M USD) and Gross Margin (2013-2018)
  • Table Global Novel Drug Delivery Systems Revenue (M USD) by Types (2013-2018)
  • Table Global Novel Drug Delivery Systems Revenue Share by Types (2013-2018)
  • Figure Revenue Share of Novel Drug Delivery Systems by Types (2013-2018)
  • Figure 2017 Revenue Market Share of Novel Drug Delivery Systems by Types
  • Figure Global Novel Drug Delivery Systems Revenue Growth Rate by Types (2013-2018)
  • Table Global Novel Drug Delivery Systems Revenue (M USD) by Applications (2013-2018)
  • Table Global Novel Drug Delivery Systems Revenue Market Share by Applications (2013-2018)
  • Figure Global Novel Drug Delivery Systems Revenue Market Share by Applications (2013-2018)
  • Figure Global Novel Drug Delivery Systems Revenue Market Share by Applications in 2017
  • Figure Global Novel Drug Delivery Systems Revenue Growth Rate by Applications (2013-2018)
  • Table Amgen Company Profile
  • Figure Novel Drug Delivery Systems Product Information of Amgen
  • Table Novel Drug Delivery Systems Revenue (M USD) Cost (M USD), Gross Profit (M USD) and Gross Margin of Amgen (2017 and 2018)
  • Table Teva Company Profile
  • Figure Novel Drug Delivery Systems Product Information of Teva
  • Table Novel Drug Delivery Systems Revenue (M USD) Cost (M USD), Gross Profit (M USD) and Gross Margin of Teva (2017 and 2018)
  • Table UCB (Union Chimique Belge) Company Profile
  • Figure Novel Drug Delivery Systems Product Information of UCB (Union Chimique Belge)
  • Table Novel Drug Delivery Systems Revenue (M USD) Cost (M USD), Gross Profit (M USD) and Gross Margin of UCB (Union Chimique Belge) (2017 and 2018)
  • Table Roche Company Profile
  • Figure Novel Drug Delivery Systems Product Information of Roche
  • Table Novel Drug Delivery Systems Revenue (M USD) Cost (M USD), Gross Profit (M USD) and Gross Margin of Roche (2017 and 2018)
  • Table Celgene Company Profile
  • Figure Novel Drug Delivery Systems Product Information of Celgene
  • Table Novel Drug Delivery Systems Revenue (M USD) Cost (M USD), Gross Profit (M USD) and Gross Margin of Celgene (2017 and 2018)
  • Table Sanofi Company Profile
  • Figure Novel Drug Delivery Systems Product Information of Sanofi
  • Table Novel Drug Delivery Systems Revenue (M USD) Cost (M USD), Gross Profit (M USD) and Gross Margin of Sanofi (2017 and 2018)
  • Table Merck Company Profile
  • Figure Novel Drug Delivery Systems Product Information of Merck
  • Table Novel Drug Delivery Systems Revenue (M USD) Cost (M USD), Gross Profit (M USD) and Gross Margin of Merck (2017 and 2018)
  • Table Johnson & Johnson Company Profile
  • Figure Novel Drug Delivery Systems Product Information of Johnson & Johnson
  • Table Novel Drug Delivery Systems Revenue (M USD) Cost (M USD), Gross Profit (M USD) and Gross Margin of Johnson & Johnson (2017 and 2018)
  • Table Takeda Company Profile
  • Figure Novel Drug Delivery Systems Product Information of Takeda
  • Table Novel Drug Delivery Systems Revenue (M USD) Cost (M USD), Gross Profit (M USD) and Gross Margin of Takeda (2017 and 2018)
  • Table Gilead Sciences Company Profile
  • Figure Novel Drug Delivery Systems Product Information of Gilead Sciences
  • Table Novel Drug Delivery Systems Revenue (M USD) Cost (M USD), Gross Profit (M USD) and Gross Margin of Gilead Sciences (2017 and 2018)
  • Table Pfizer Company Profile
  • Figure Novel Drug Delivery Systems Product Information of Pfizer
  • Table Novel Drug Delivery Systems Revenue (M USD) Cost (M USD), Gross Profit (M USD) and Gross Margin of Pfizer (2017 and 2018)
  • Table Dr Reddy Company Profile
  • Figure Novel Drug Delivery Systems Product Information of Dr Reddy
  • Table Novel Drug Delivery Systems Revenue (M USD) Cost (M USD), Gross Profit (M USD) and Gross Margin of Dr Reddy (2017 and 2018)
  • Table Samyang Biopharmaceuticals Company Profile
  • Figure Novel Drug Delivery Systems Product Information of Samyang Biopharmaceuticals
  • Table Novel Drug Delivery Systems Revenue (M USD) Cost (M USD), Gross Profit (M USD) and Gross Margin of Samyang Biopharmaceuticals (2017 and 2018)
  • Table TOLMAR Company Profile
  • Figure Novel Drug Delivery Systems Product Information of TOLMAR
  • Table Novel Drug Delivery Systems Revenue (M USD) Cost (M USD), Gross Profit (M USD) and Gross Margin of TOLMAR (2017 and 2018)
  • Table Astellas Company Profile
  • Figure Novel Drug Delivery Systems Product Information of Astellas
  • Table Novel Drug Delivery Systems Revenue (M USD) Cost (M USD), Gross Profit (M USD) and Gross Margin of Astellas (2017 and 2018)
  • Table AMAG Pharmaceuticals Company Profile
  • Figure Novel Drug Delivery Systems Product Information of AMAG Pharmaceuticals
  • Table Novel Drug Delivery Systems Revenue (M USD) Cost (M USD), Gross Profit (M USD) and Gross Margin of AMAG Pharmaceuticals (2017 and 2018)
  • Table AstraZeneca Company Profile
  • Figure Novel Drug Delivery Systems Product Information of AstraZeneca
  • Table Novel Drug Delivery Systems Revenue (M USD) Cost (M USD), Gross Profit (M USD) and Gross Margin of AstraZeneca (2017 and 2018)
  • Table AbbVie Company Profile
  • Figure Novel Drug Delivery Systems Product Information of AbbVie
  • Table Novel Drug Delivery Systems Revenue (M USD) Cost (M USD), Gross Profit (M USD) and Gross Margin of AbbVie (2017 and 2018)
  • Table Bausch&Lomb Company Profile
  • Figure Novel Drug Delivery Systems Product Information of Bausch&Lomb
  • Table Novel Drug Delivery Systems Revenue (M USD) Cost (M USD), Gross Profit (M USD) and Gross Margin of Bausch&Lomb (2017 and 2018)
  • Table TWi Pharmaceuticals Company Profile
  • Figure Novel Drug Delivery Systems Product Information of TWi Pharmaceuticals
  • Table Novel Drug Delivery Systems Revenue (M USD) Cost (M USD), Gross Profit (M USD) and Gross Margin of TWi Pharmaceuticals (2017 and 2018)
  • Table Novartis Company Profile
  • Figure Novel Drug Delivery Systems Product Information of Novartis
  • Table Novel Drug Delivery Systems Revenue (M USD) Cost (M USD), Gross Profit (M USD) and Gross Margin of Novartis (2017 and 2018)
  • Table Aspen Company Profile
  • Figure Novel Drug Delivery Systems Product Information of Aspen
  • Table Novel Drug Delivery Systems Revenue (M USD) Cost (M USD), Gross Profit (M USD) and Gross Margin of Aspen (2017 and 2018)
  • Table Shire Company Profile
  • Figure Novel Drug Delivery Systems Product Information of Shire
  • Table Novel Drug Delivery Systems Revenue (M USD) Cost (M USD), Gross Profit (M USD) and Gross Margin of Shire (2017 and 2018)
  • Table Breckenridge Pharmaceuticals Company Profile
  • Figure Novel Drug Delivery Systems Product Information of Breckenridge Pharmaceuticals
  • Table Novel Drug Delivery Systems Revenue (M USD) Cost (M USD), Gross Profit (M USD) and Gross Margin of Breckenridge Pharmaceuticals (2017 and 2018)
  • Table Galen Company Profile
  • Figure Novel Drug Delivery Systems Product Information of Galen
  • Table Novel Drug Delivery Systems Revenue (M USD) Cost (M USD), Gross Profit (M USD) and Gross Margin of Galen (2017 and 2018)
  • Figure Typical Phases from Research to Market for a Drug Candidate
  • Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound
  • Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound
  • Figure Manufacturing Cost Structure of Novel Drug Delivery Systems
  • Figure USA Labor Cost Analysis 2015-2018
  • Figure Cost of Employing a Factory Worker
  • Figure Europe Labor Cost Analysis 2015-2018
  • Figure Germany Labor Cost Analysis 2015-2018
  • Figure UK Labor Cost Analysis 2015-2018
  • Figure France Labor Cost Analysis 2015-2018
  • Figure Italy Labor Cost Analysis 2015-2018
  • Figure Monthly Minimum Wages in Asia 2016
  • Figure China Labor Costs 2015-2018
  • Figure Japan Average Monthly Wages 2015-2018
  • Figure Global Electricity Prices by Select Countries in 2017 (in U.S. Dollars per Kilowatt Hour)
  • Table Average Price of Electricity to Ultimate Customers 2007-2018
  • Figure Electricity Prices for Household Consumers in 2017
  • Table China Cost of Electricity 2017 (PER KWH)
  • Figure Manufacturing Process Analysis of Novel Drug Delivery Systems
  • Figure Novel Drug Delivery Systems Industrial Chain Analysis
  • Table Major Buyers of Novel Drug Delivery Systems
  • Figure Marketing Channel for Biopharmaceuticals
  • Figure Conceptual Model of the Flow of Products, Services and Funds for Non-specialty Drugs Coveredunder Private Insurance and Purchased in a Retail Setting
  • Figure Marketing Channel for Biopharmaceuticals
  • Figure Flow of US Prescription Sales Contribution by Channel
  • Table Distributors/Traders List
  • Figure Types of Drug Delivery
  • Figure Global GDP Growth Rate for 2016
  • Figure Real GDP Growth 2016-2020 annual Average
  • Figure USA GDP 2008-2016 (Billion USD)
  • Figure USA GDP Growth Rate Change 2015-2018
  • Figure EU GDP 2008-2016 (Billion USD)
  • Figure EU GDP Growth Rate Change 2015-2018
  • Figure Germany GDP 2008-2016 (Billion USD)
  • Figure Germany GDP Growth Rate 2015-2018
  • Figure UK GDP 2008-2016 (Billion USD)
  • Figure UK GDP Growth Rate 2015-2018
  • Figure Italy GDP 2008-2016 (Billion USD)
  • Figure Italy GDP Growth Rate 2015-2018
  • Figure France GDP 2008-2016 (Billion USD)
  • Figure France GDP Growth Rate 2015-2018
  • Figure Japan GDP 2008-2016 (Billion USD)
  • Figure Japan GDP Growth Rate 2015-2018
  • Figure China GDP 2008-2016 (Billion USD)
  • Figure China GDP Growth Rate 2015-2018
  • Figure Global Novel Drug Delivery Systems Revenue (M USD) and Growth Rate Forecast (2019-2025)
  • Table Global Novel Drug Delivery Systems Revenue (M USD) Forecast by Regions (2019-2025)
  • Table Global Novel Drug Delivery Systems Revenue Market Share Forecast by Regions (2019-2025)
  • Figure Global Novel Drug Delivery Systems Revenue Market Share Forecast by Regions (2019-2025)
  • Figure Global Novel Drug Delivery Systems Revenue Market Share Forecast by Regions in 2025
  • Figure North America Novel Drug Delivery Systems Revenue (M USD) and Growth Rate Forecast (2019-2025)
  • Figure Europe Novel Drug Delivery Systems Revenue (M USD) and Growth Rate Forecast (2019-2025)
  • Figure Asia-Pacific Novel Drug Delivery Systems Revenue (M USD) and Growth Rate Forecast (2019-2025)
  • Figure South America Novel Drug Delivery Systems Revenue (M USD) and Growth Rate Forecast (2019-2025)
  • Figure Middle East and Africa Novel Drug Delivery Systems Revenue (M USD) and Growth Rate Forecast (2019-2025)
  • Table Global Novel Drug Delivery Systems Revenue (M USD) Forecast by Types (2019-2025)
  • Table Global Novel Drug Delivery Systems Revenue Market Share Forecast by Types (2019-2025)
  • Figure Global Novel Drug Delivery Systems Revenue Market Share Forecast by Types (2019-2025)
  • Figure Global Novel Drug Delivery Systems Revenue Market Share Forecast by Types in 2025
  • Table Global Novel Drug Delivery Systems Revenue (M USD) Forecast by Application (2019-2025)
  • Table Global Novel Drug Delivery Systems Revenue Market Share Forecast by Application (2019-2025)
  • Figure Global Novel Drug Delivery Systems Revenue Market Share Forecast by Application (2019-2025)
  • Figure Global Novel Drug Delivery Systems Revenue Market Share Forecast by Application in 2025
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
Back to Top
아시아 최대 시장정보 제공
전세계에서 발행되고 있는 모든 시장조사보고서를
다루고 있습니다.
사이트에서 검색되지 않는 보고서도 문의 바랍니다.
 
La Merie Publishing
BCC Research